Indeed, treatment of murine orthotopic GBM with ICOVIR17 increased tumor-infiltrating CD8+T cells and macrophages, and upregulated PD-L1 on GBM cells and macrophages (Kiyokawa et al. 2019, 2021). The gene discussed is CD8A; the disease is neoplasm.